Nurse Practitioners Secure No. 1 Spot Across Three U.S. News & World Report Best Jobs Rankings 
Hepion Pharmaceuticals to Present at The Liver Meeting Digital Experience(TM) 2020
EDISON, NJ / ACCESSWIRE / November 12, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on...
Cancer Tissue Diagnostics Demand Augmenting Due to Rising Prevalence of Cancer: Future Market Insights
Players in the cancer tissue diagnostics market are adopting merger & acquisition strategies to boost their market presence. DUBAI, UAE...
PainReform Welcomes Successful Healthcare and Capital Markets Executive Dr. Ellen Baron to Board of Directors
HERZLIYA, ISRAEL / ACCESSWIRE / November 12, 2020 / PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical...
Halberd Corporation Reveals Patent-Pending Fluorescent Antibody’s Wide Role in Covid-19 Detection & Treatment
JACKSON CENTER, PA / ACCESSWIRE / November 12, 2020 / Halberd Corporation (OTC PINK:HALB) today disclosed information on their patent-pending...
Zealand Pharma continues to advance clinical programs and commercial launch capabilities and presents financial results for the first nine months of 2020
Interim report for 9M 2020 Financial results for the first nine months of 2020 Revenue: DKK 290.0 million / USD...
Foghorn Therapeutics Appoints Michael LaCascia as Chief Legal Officer
CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development...
Agenus and Dr. Steven O’Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of...
Neuropathix, Inc. Reveals Visual Identity to Coincide With Its Mission for Socially Responsible Pain Management
DOYLESTOWN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. ("Neuropathix" or the “Company”) (OTCQB: NPTX), formerly Kannalife, Inc., is...
Generex Biotechnology Announces Interview with Richard Purcell EVP of R&D on the Yo! Dr.Yo Show with an Update on the Ii-Key COVID Vaccine Program
Livestream Interview on Friday November 13 at 2 PM EST MIRAMAR, Fla., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology...
Atreca Reports Third Quarter 2020 Financial Results and Recent Corporate Developments
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused...
Allogene Therapeutics Announces November and December 2020 Virtual Investor Conference Participation
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
Primo Nutraceuticals Inc. Enters intoa Binding LOI to acquire 100% of the Assets of Full Spectrum Biosciences Inc.
VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) -- PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF ) (FSE: 8BV) (DEU:...
Aligos Therapeutics is awarded €1.8M VLAIO grant to advance chronic hepatitis B research
SOUTH SAN FRANCISCO, Calif. and LEUVEN, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical...
Resverlogix Announces Publication in High-impact, Peer-reviewed Journal, Clinical Epigenetics
Publication Explores the Beneficial Effects of Apabetalone on the Immune Cells of Diabetic Patients Event Reminder: Multiple Presentations on Apabetalone...
eFFECTOR Announces Dosing of First Breast Cancer Patient with Tomivosertib in Combination with Chemotherapy Through a Grant from Stand Up To Cancer® (SU2C) Canada
SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulation...
Better Choice Launches New Corporate and Store Websites Designed to Meet Increasing Consumer Demand and Expand Investor Awareness
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQB: BTTR) (“Better Choice”), an animal health and wellness...
Immunovant Reports Financial Results for the Quarter and Six Months Ended September 30, 2020
Company Ended the Quarter With Cash of Approximately $444 Million NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Immunovant, Inc....
Biotricity Launches Biocare Telemed for Safe and Convenient Remote Patient Care
Secure HIPAA compliant technology for at-risk chronic care patients REDWOOD CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc....
Harmony Biosciences Reports Third Quarter 2020 Financial Results and Business Updates
WAKIX®(pitolisant) Total Revenue of $45.6 Million for Third Quarter of 2020 Differentiated Product Profile Aligns with Unmet Medical Need On...
Alimera Sciences Announces Real-World Clinical Data for ILUVIEN® to be Presented at the American Academy of Ophthalmology 2020 Virtual Conference
ATLANTA, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development...